National Health (Chemotherapy Pharmaceuticals Access Program) Special Arrangement 2010 (No. PB 117 of 2010)
© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.
National Health (Chemotherapy Pharmaceuticals Access Program) Special Arrangement 2010 (No. PB 117 of 2010)
Start here
Turn the raw legal text into a practical explanation grounded in National Health (Chemotherapy Pharmaceuticals Access Program) Special Arrangement 2010 (No. PB 117 of 2010).
12 Authority required procedures
(1) This section applies to a chemotherapy pharmaceutical benefit if the circumstances mentioned in Schedule 3 for a circumstances code mentioned in Schedule 1 for the chemotherapy pharmaceutical benefit include any of the following:
(a) Compliance with Authority Required procedures;
(b) Compliance with Written Authority Required procedures;
(c) Compliance with Telephone Authority Required procedures;
(d) Compliance with Written or Telephone Authority Required procedures.
(2) A prescription written in accordance with paragraph 10 (1) (a) for the supply of the chemotherapy pharmaceutical benefit must be:
(a) submitted by the eligible medical practitioner to the Chief Executive Medicare in accordance with section 13; and
(b) authorised by the Chief Executive Medicare in accordance with section 14.
(3) A medication chart prepared in accordance with paragraph 10 (1) (b) for the supply of the chemotherapy pharmaceutical benefit must be:
(a) submitted by a pharmacist employed by the approved hospital authority to the Chief Executive Medicare in accordance with section 15; and
(b) authorised by the Chief Executive Medicare in accordance with section 16.